Longevity has become one of the biggest buzzwords in health tech, and Withings is leaning in hard with the Body Scan 2, a $600 smart scale designed to paint a more complete picture of your health than just a standard bathroom weigh-in ever could.
Launched at CES 2026 as part of the wave of Consumer Electronics Show announcements, the Body Scan 2 is packed with firsts for an at-home device. It promises to assess everything from your risk of hypertension (high blood pressure) to early signs of glycemic dysregulation (a precursor to diabetes). In total, Withings says the scale measures more than 60 biomarkers that can influence long-term health, aging and the risk of chronic illness.
The goal isn’t just to show you numbers, but to spot small physiological changes early — while they’re still reversible — and guide you toward lifestyle changes that, over time, could extend and improve your quality of life.
The Body Scan 2 still looks like a futuristic bathroom scale with a pull-up exercise bar tied to the top. It has a flat tempered-glass surface and a retractable handle bar that’s connected by a cord. That handle has a color screen that displays on-the-spot metrics during weigh-ins.
Under the glasshood, the scale uses eight embedded electrodes in the platform and four stainless steel electrodes in the handle to collect its data and automatically sync data via Wi-Fi or Bluetooth to the Withings app on your iPhone or Android. It runs on a rechargeable battery that Withings says can last up to 15 months.
Don’t miss any of our unbiased tech content and lab-based reviews. Add CNET as a preferred Google source.
Withings isn’t new to this space. The company created one of the original connected scales back in 2009 and has since expanded into smartwatches, blood pressure monitors and other connected health devices. Body Scan 2 seems to be a culmination of all of these efforts, turning what used to be a single-measurement device into what the company calls an “at-home longevity station.”
Longevity has become a major theme in health tech, as companies look beyond the narrow snapshots captured during doctor visits. Instead, they’re starting to focus more on continuous, big-picture monitoring that reflects how people actually live day-to-day. Withings is betting that frequent, at-home measurements can help catch early warning signs related to heart health, metabolism or blood sugar regulation long before they turn into chronic conditions like diabetes, hypertension or heart disease.
Turning a mountain of metrics into actionable insights
According to Withings, the Body Scan 2 uses five medical-grade technologies that, until now, have largely been limited to clinical or research settings. Combined, they track 60 biomarkers that fall into three core categories:
Heart and vascular health: The scale can flag your potential risk for high blood pressure without using a traditional cuff, similar to the blood pressure notifications found on newer Apple Watch models. It also looks at how efficiently your heart is pumping blood and the flexibility of your arteries. Together, these measurements offer early clues about heart health and whether your cardiovascular system may be under extra strain.
Cellular and metabolic health: The scale also looks at how efficiently your body uses energy at the cellular level and how your cells are aging. These measurements can offer insight into whether factors like stress, inactivity, inflammation or diet may be affecting your overall health.
Diet and glycemic regulation: The scale also looks for early signs of glycemic dysregulation, or how well your body manages blood sugar. Poor regulation can be a precursor to prediabetes and cause fatigue, abdominal fat gain, and ultimately accelerate aging (often without any obvious symptoms).
After a roughly 90-second weigh-in which requires you to pull the handle bar up to hip level, the app uses these measurements to come up with what Withings calls a Health Trajectory score that you can view in the Withings app. It establishes a personalized baseline for your health and tracks how it trends over time, rather than focusing on daily fluctuations.
Beyond the score itself, the app flags any major changes from that baseline and gives you guidance on lifestyle adjustments that could help correct any negative trends. The idea is to spot potential issues early, when they’re more likely to be reversible, and give you a preview of how those changes can influence long-term health.
As with all health data, privacy is a major concern. Withings addresses this by disclosing that the Body Scan 2 complies with GDPR and HIPAA, and carries ISO 27001 and ISO 27701 certifications for data security and privacy management.
Pricing and availability
Body Scan 2 is pending FDA clearance for select metrics and is scheduled to launch in Q2 2026. Pricing is set at $600, £450 and AU$899, respectively. It will be available through Withings, Amazon and select retailers.
We haven’t tested Body Scan 2 yet, but we’ll update our coverage once we’re able to spend time with it in the real world.
For more product launches and first looks ahead of CES 2026, check out CNET’s full CES coverage.
Read the full article here